India Is Powering the Fight Against a Silent ‘Superbug’ Pandemic
A Scientist working with a petri dish.
Photographer: Samyukta Lakshmi/BloombergThis article is for subscribers only.
Hi, I’m Satviki from Mumbai. An old but relatively little-known Indian pharmaceutical company is the latest to join the fight against antimicrobial resistance.
Antimicrobial resistance, or AMR, isn’t new. Not long after the introduction of penicillin for the treatment of bacterial infections in 1943, resistance was observed for Staphylococcus aureus - a bacteria that causes skin infection. That was followed by pneumococcal penicillin resistance in the 1960s, causing pneumonia and meningitis and, in turn, increased mortality.